HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multiple endocrine neoplasia type 1 in children and adolescents: Clinical features and treatment outcomes.

AbstractBACKGROUND:
Clinical manifestations and treatment outcomes in children and adolescents with multiple endocrine neoplasia type 1 are not well characterized.
METHODS:
We conducted a retrospective cohort study of 80 patients with multiple endocrine neoplasia type 1 who commenced tumor surveillance at ≤18 years of age.
RESULTS:
Fifty-six patients (70%) developed an endocrine tumor by age ≤18 years (median age = 14 years, range = 6-18 years). Primary hyperparathyroidism occurred in >80% of patients, with >70% undergoing parathyroidectomy, in which less-than-subtotal (<3-gland) resection resulted in decreased disease-free outcomes versus subtotal (3-3.5-gland) or total (4-gland) parathyroidectomy (median 27 months versus not reached; P = .005). Pancreaticoduodenal neuroendocrine tumors developed in ∼35% of patients, of whom >70% had nonfunctioning tumors, >35% had insulinomas, and <5% had gastrinomas, with ∼15% having metastases and >55% undergoing surgery. Pituitary tumors developed in >30% of patients, and ∼35% were macroprolactinomas. Tumor occurrence in male patients and female patients was not significantly different. Genetic analyses revealed 38 germline MEN1 mutations, of which 3 were novel.
CONCLUSION:
Seventy percent of children aged ≤18 years with multiple endocrine neoplasia type 1 develop endocrine tumors, which include parathyroid tumors for which less-than-subtotal parathyroidectomy should be avoided; pancreaticoduodenal neuroendocrine tumors that may metastasize; and pituitary macroprolactinomas.
AuthorsOmair A Shariq, Kate E Lines, Katherine A English, Bahram Jafar-Mohammadi, Philippa Prentice, Ruth Casey, Benjamin G Challis, Andreas Selberherr, Hannah Boon, Treena Cranston, Fiona J Ryan, Radu Mihai, Ultan Healy, Tom Kurzawinski, Mehul T Dattani, Irina Bancos, Benzon M Dy, Melanie L Lyden, William F Young Jr, Travis J McKenzie, Duncan Richards, Rajesh V Thakker
JournalSurgery (Surgery) Vol. 171 Issue 1 Pg. 77-87 (01 2022) ISSN: 1532-7361 [Electronic] United States
PMID34183184 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2021 Elsevier Inc. All rights reserved.
Topics
  • Adolescent
  • Child
  • Duodenal Neoplasms (epidemiology, genetics, surgery)
  • Female
  • Humans
  • Hyperparathyroidism, Primary (epidemiology, genetics, surgery)
  • Male
  • Multiple Endocrine Neoplasia Type 1 (complications, genetics, surgery)
  • Pancreatic Neoplasms (epidemiology, genetics, surgery)
  • Parathyroid Neoplasms (epidemiology, genetics, surgery)
  • Parathyroidectomy (statistics & numerical data)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: